Xu Wen – Trademark Portfolio
Entity Type: 01
Xu Wen owns a portfolio of 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as HYLOXS, LAIFUG, TCLLKA, LATOMEX, and TRUBEST. Of these, 11 are registered. The portfolio spans 7 Nice Classification classes, led by Class 20 (Furniture) and Class 9 (Computers & Electronics). Headquartered in Yangzhou, Jiangsu.
Room 501, Building 4, No.20 Huayuan Road
Jiangdu District
Yangzhou, Jiangsu 225000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xu Wen's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Common metals and their alloys; metal building materials; transportable buildings of metal
Frequently Asked Questions
How many trademarks does Xu Wen have?
Xu Wen has 14 U.S. trademarks filed with the USPTO. Of these, 11 registered, 2 abandoned, 1 cancelled.
What trademark classes does Xu Wen file in?
Xu Wen files trademarks across 7 Nice Classification classes. The most active classes are Class 20 (Furniture), Class 9 (Computers & Electronics), Class 16 (Paper Goods), Class 28 (Toys & Sporting Goods), Class 6 (Metal Goods). Class 20 covers furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker.
What are Xu Wen's most well-known trademarks?
Xu Wen's registered trademark portfolio includes well-known marks such as HYLOXS, LAIFUG, TCLLKA, LATOMEX, and TRUBEST. These are among 11 currently registered trademarks in the portfolio.
What is Xu Wen's trademark registration success rate?
Xu Wen has a 79% trademark registration rate, with 11 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.